American Healthcare REIT (AHR) reported Q4 FY2025 GAAP net income attributable to controlling interest of USD 10.8 million (USD 0.06 per diluted share) and normalized FFO (NFFO) of USD 0.46 per diluted share. Total revenues were USD 604.1 million (+11.3%) and net operating income (NOI) was USD 111.6 million (+12.6%). Total portfolio same-store NOI growth was 11.8% in Q4, led by SHOP at 24.6% and ISHC at 14.0%. For FY2025, AHR reported GAAP net income attributable to controlling interest of USD 69.8 million (USD 0.42 per diluted share) and NFFO of USD 1.72 per diluted share. Total portfolio same-store NOI growth was 14.2% for FY2025. AHR said it completed over USD 950.0 million of acquisitions during FY2025 (USD 370.0 million in ISHC and USD 590.0 million in SHOP) and sold two non-core properties for USD 3.9 million in Q4. Subsequent to year-end, AHR acquired five SHOP assets for USD 117.5 million and reported an investments pipeline of over USD 230.0 million in awarded deals. AHR declared a Q4 cash distribution of USD 0.25 per share, paid on January 16, 2026. As of December 31, 2025, AHR reported total consolidated indebtedness of USD 1.54 billion, total liquidity of approximately USD 1.14 billion, and net debt-to-annualized adjusted EBITDA of 3.4x. For FY2026, AHR guided to NFFO per diluted share of USD 1.99 to USD 2.05 and total portfolio same-store NOI growth of 7.0% to 11.0%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Healthcare REIT Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602261615PR_NEWS_USPR_____LA96912) on February 26, 2026, and is solely responsible for the information contained therein.